Verbatim response from Perplexity
Some telehealth services still offer compounded GLP-1s, but availability has narrowed and the FDA has specifically warned 30 telehealth companies against illegally marketing compounded GLP-1 products.[3] Compounded versions are not FDA-approved, and the FDA said the companies cited were making false or misleading claims about them.[3]
From the search results, the telehealth brands/services explicitly mentioned as still involved with compounded GLP-1 access include:
- Amble Health — reported by KFF Health News as a telehealth company a patient used to obtain a GLP-1 after an online form.[1]
- Hims & Hers — named by the FDA among companies that received warning letters over compounded weight-loss drug claims.[1][3]
- SkinnyRx — also named in the FDA warning-letter sweep.[1][3]
- Join Josie — named in the FDA warning-letter sweep.[1][3]
- Genesis Health International — named in the FDA warning-letter sweep.[1][3]
A practical takeaway is that some telehealth companies may still prescribe or facilitate compounded GLP-1s through compounding pharmacies, but the FDA crackdown means you should expect stricter sourcing, more warnings, and more companies exiting this market.[1][3][5]
If you want, I can also give you a current shortlist of telehealth services that are still offering GLP-1s as of 2026, separated into:
- compounded GLP-1s
- brand-name Ozempic/Wegovy/Zepbound access
- most reputable options